Literature DB >> 27586377

Treatment of Metastatic Prostate Cancer in Older Adults.

Kah Poh Loh1, Supriya G Mohile2, Elizabeth Kessler3, Chunkit Fung2.   

Abstract

The aging of the population, along with rising life expectancy, means that increasing numbers of older men will be diagnosed with prostate cancer, and a large proportion of these men will present with metastatic disease. In this paper, we discuss recent advances in prostate cancer treatment. In particular, we review management approaches for older patients with metastatic prostate cancer based on the decision tree developed by the International Society of Geriatric Oncology, which categorized older men as "fit," "vulnerable," and "frail" according to comprehensive geriatric assessment.

Entities:  

Keywords:  Geriatric assessment; Older adults; Prostate cancer

Mesh：

Substances：

Year:  2016        PMID： 27586377     DOI： 10.1007/s11912-016-0548-3

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  67 in total

1.  Decreasing use of luteinizing hormone-releasing hormone agonists in the United States is Independent of Reimbursement Changes: A Medicare and Veterans Health Administration claims analysis.

Authors:  Steven L Chang; Joseph C Liao; Rajesh Shinghal
Journal:  J Urol       Date:  2009-05-17       Impact factor: 7.450

Review 2.  Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-analysis.

Authors:  Sindy Magnan; Ryan Zarychanski; Laurie Pilote; Laurence Bernier; Michèle Shemilt; Eric Vigneault; Vincent Fradet; Alexis F Turgeon
Journal:  JAMA Oncol       Date:  2015-12       Impact factor: 31.777

3.  Androgen deprivation therapy in prostate cancer: are rising concerns leading to falling use?

Authors:  Murray Krahn; Karen E Bremner; George Tomlinson; Jin Luo; Paul Ritvo; Gary Naglie; Shabbir M H Alibhai
Journal:  BJU Int       Date:  2011-03-31       Impact factor: 5.588

4.  Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix.

Authors:  Michael J Zelefsky; James A Eastham; Angel M Cronin; Zvi Fuks; Zhigang Zhang; Yoshiya Yamada; Andrew Vickers; Peter T Scardino
Journal:  J Clin Oncol       Date:  2010-02-16       Impact factor: 44.544

5.  Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.

Authors:  Ian F Tannock; Ronald de Wit; William R Berry; Jozsef Horti; Anna Pluzanska; Kim N Chi; Stephane Oudard; Christine Théodore; Nicholas D James; Ingela Turesson; Mark A Rosenthal; Mario A Eisenberger
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

Review 6.  Treatment of prostate cancer with intermittent versus continuous androgen deprivation: a systematic review of randomized trials.

Authors:  Saroj Niraula; Lisa W Le; Ian F Tannock
Journal:  J Clin Oncol       Date:  2013-04-29       Impact factor: 44.544

7.  Optimizing the G8 Screening Tool for Older Patients With Cancer: Diagnostic Performance and Validation of a Six-Item Version.

Authors:  Claudia Martinez-Tapia; Florence Canoui-Poitrine; Sylvie Bastuji-Garin; Pierre Soubeyran; Simone Mathoulin-Pelissier; Christophe Tournigand; Elena Paillaud; Marie Laurent; Etienne Audureau
Journal:  Oncologist       Date:  2016-01-13

8.  Performance of two geriatric screening tools in older patients with cancer.

Authors:  Cindy Kenis; Lore Decoster; Katrien Van Puyvelde; Jacques De Grève; Godelieve Conings; Koen Milisen; Johan Flamaing; Jean-Pierre Lobelle; Hans Wildiers
Journal:  J Clin Oncol       Date:  2013-11-25       Impact factor: 44.544

9.  Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.

Authors:  Pierre Soubeyran; Carine Bellera; Jean Goyard; Damien Heitz; Hervé Curé; Hubert Rousselot; Gilles Albrand; Véronique Servent; Olivier Saint Jean; Isabelle van Praagh; Jean-Emmanuel Kurtz; Stéphane Périn; Jean-Luc Verhaeghe; Catherine Terret; Christophe Desauw; Véronique Girre; Cécile Mertens; Simone Mathoulin-Pélissier; Muriel Rainfray
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

10.  Four screening instruments for frailty in older patients with and without cancer: a diagnostic study.

Authors:  Ineke H G J Smets; Gertrudis I J M Kempen; Maryska L G Janssen-Heijnen; Laura Deckx; Frank J V M Buntinx; Marjan van den Akker
Journal:  BMC Geriatr       Date:  2014-02-26       Impact factor: 3.921
View more
  3 in total

Review 1.  Next-Generation Androgen Receptor-Signaling Inhibitors for Prostate Cancer: Considerations for Older Patients.

Authors:  Zizhen Feng; Julie N Graff
Journal:  Drugs Aging       Date:  2021-02-09       Impact factor: 3.923

2.  Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate Cancer.

Authors:  Shuyi Fang; Jake L Owens; Elena Beketova; Sheng Liu; Xufeng Chen; Qingfu Zhang; Andrew M Asberry; Xuehong Deng; Jonathan Malola; Jiaoti Huang; Chenglong Li; Roberto Pili; Bennett D Elzey; Timothy L Ratliff; Jun Wan; Chang-Deng Hu
Journal:  Cancer Res       Date:  2020-09-30       Impact factor: 12.701

3.  A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis from Co-Occurring Prostate Cancer.

Authors:  Miyeong Park; Sang-Ho Jeong; Young-Joon Lee; Ji-Ho Park; Sang-Kyung Choi; Soon-Chan Hong; Eun-Jung Jung; Young-Tae Ju; Chi-Young Jeong; Jeong-Hee Lee; Woo-Song Ha
Journal:  J Gastric Cancer       Date:  2017-03-10       Impact factor: 3.720
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.